These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2064112)

  • 1. Individualized therapy versus standard regimens in the treatment of Mycobacterium avium infections.
    Heifets LB; Iseman MD
    Am Rev Respir Dis; 1991 Jul; 144(1):1-2. PubMed ID: 2064112
    [No Abstract]   [Full Text] [Related]  

  • 2. [Relationship between the susceptibility testing of Mycobacterium avium complex strains and the clinical efficacy of antituberculosis drugs--an evidence suggesting that antituberculosis drugs are effective in the treatment of M. avium complex pulmonary infection].
    Tsukamura M; Ichiyama S; Miyachi T
    Kekkaku; 1988 Apr; 63(4):227-31. PubMed ID: 3404801
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of experimental mycobacteriosis].
    Aleksandrova AE; Lozovskaia ME; Ariel' BM; Otten TF
    Probl Tuberk; 1988; (9):47-52. PubMed ID: 3231623
    [No Abstract]   [Full Text] [Related]  

  • 4. A plea for clinical trials to resolve the issue of optimal therapy in the treatment of Mycobacterium avium infection.
    Wallace RJ; Glassroth J; O'Brien R
    Am Rev Respir Dis; 1991 Jul; 144(1):3-4. PubMed ID: 2064136
    [No Abstract]   [Full Text] [Related]  

  • 5. Disseminated infection with Mycobacterium avium: I. Clinical features, treatment and pathology.
    Schonell ME; Crofton JW; Stuart AE; Wallace A
    Tubercle; 1968 Mar; 49(1):12-30. PubMed ID: 4969143
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical analysis of 41 cases of pulmonary atypical mycobacteriosis].
    Xia XX
    Zhonghua Jie He He Hu Xi Za Zhi; 1992 Aug; 15(4):200-1, 253. PubMed ID: 1307510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of therapeutic regimens with antituberculosis agents in the initial treatment of lung infection caused by Mycobacterium avium complex].
    Tsukamura M; Ichiyama S; Miyachi T
    Kekkaku; 1987 Aug; 62(8):403-8. PubMed ID: 3430944
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence that antituberculosis drugs are really effective in the treatment of pulmonary infection caused by Mycobacterium avium complex.
    Tsukamura M
    Am Rev Respir Dis; 1988 Jan; 137(1):144-8. PubMed ID: 3337455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary tuberculosis. 2. Therapy].
    Bölcskei P
    Fortschr Med; 1983 Jun; 101(23):1075-80, 1090. PubMed ID: 6411560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative study of the susceptibilities to antituberculosis agents between Mycobacterium tuberculosis and Mycobacterium avium complex strains].
    Tsukamura M
    Kekkaku; 1987 Jun; 62(6):345-8. PubMed ID: 3116312
    [No Abstract]   [Full Text] [Related]  

  • 12. [Analysis of failures of chemotherapy of pulmonary tuberculosis in adults].
    Anastasatu C; Mihăilescu P; Gartner A; Bogdănescu V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(3):153-8. PubMed ID: 229540
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment and prognosis in cases of M. avium-intracellulare infection].
    Kekkaku; 1987 Nov; 62(11):575-601. PubMed ID: 3444198
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of pulmonary tuberculosis patients with primary drug resistant Mycobacterium tuberculosis].
    Protopopova NM; Bessonova GS; Cherednichenko LP
    Probl Tuberk; 1987; (1):27-30. PubMed ID: 3104897
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to therapy of pulmonary Mycobacterium avium-intracellulare infection correlates with results of in vitro susceptibility testing.
    Horsburgh CR; Mason UG; Heifets LB; Southwick K; Labrecque J; Iseman MD
    Am Rev Respir Dis; 1987 Feb; 135(2):418-21. PubMed ID: 3813205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tuberculosis, does it always come out right?].
    Steensma JT
    Ned Tijdschr Geneeskd; 1986 Jan; 130(4):145-7. PubMed ID: 3513030
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative results of treatment of pulmonary tuberculosis with the compounds of benzoyl-PAS-Ca-isoniazide and streptomycin-isoniazid].
    Favez G; Gonin JD; Gubéran E; de Kalbermatten JP; Vulliémoz P; Willa C
    Schweiz Med Wochenschr; 1969 Feb; 99(5):150-6. PubMed ID: 4974643
    [No Abstract]   [Full Text] [Related]  

  • 18. [In vitro activities of rifabutine and rifampicin against various mycobacteria, especially Mycobacterium tuberculosis and Mycobacterium avium complex].
    Saito H; Sato K; Tomioka H
    Kekkaku; 1988 Mar; 63(3):167-72. PubMed ID: 2836649
    [No Abstract]   [Full Text] [Related]  

  • 19. Modern short-course regimens in the treatment of tuberculosis.
    Fox W
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(2):122-32. PubMed ID: 2999948
    [No Abstract]   [Full Text] [Related]  

  • 20. [Resistance problems in Mycobacteria tuberculosis and the treatment of severe tuberculosis with secondary antitubercular agents].
    Vojtek J; Holecková R; Rozánek R; Starosta V; Strnad M; Sebests J; Strusa V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1965; 8(5):589-92. PubMed ID: 4955225
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.